# Qualitative analysis — gemma-3-4b-it / test_ood

Case identifiers are configured in `src/eval/qualitative.py` (`CASE_IDS`).

| Case | id | `gemma-3-4b-it` | `gemma-3-4b-it-qlora-finetune` | `medgemma-4b-it` |
|---|---|---|---|---|
| 3 | `test_ood-00207` | `A` ✓ | `B` ✗ | `A` ✓ |

---

## Case 3

- **id**: `test_ood-00207`
- **gold**: `A`
- **predicted**: `A` (parse_success=True)

**Model generation:**

```text
Okay, let's break down this case and determine the most appropriate management for a newly diagnosed CIN I in a 28-year-old woman. Here’s my thought process:

1. **Understanding CIN I:** Cervical Intraepithelial Neoplasia (CIN) represents precancerous changes in the cells lining the cervix. CIN I is considered a mild dysplasia – it indicates cellular abnormalities but doesn't yet represent full-blown cancer. It has a high rate of regression spontaneously.

2. **Patient Age & Risk Factors:**  The patient is relatively young (28 years old). Young women have a higher spontaneous regression rate of CIN lesions compared to older women. This significantly influences our approach. Furthermore, her history is non-contributory, meaning there aren't specific risk factors like persistent HPV infection or prior abnormal Pap smears that would necessitate more aggressive intervention.

3. **Evaluating Options:** Let's analyze each option:

   * **A) Close Observation with PAP Smear Screening at 6 and 12 Months, and HPV DNA Testing at 12 Months:** This is the *most* recommended strategy for low-grade CIN like CIN I in younger patients. Given the high regression rate, immediate treatment isn't always necessary. Regular monitoring allows us to see if the lesion resolves itself. HPV DNA testing can help identify the causative virus, which informs long-term surveillance strategies.

   * **B) Cryotherapy Ablation:** Cryotherapy freezes and destroys the affected tissue. While effective, it's generally reserved for slightly more advanced dysplasias (CIN II or III), or when regression is unlikely. For CIN I, especially in a younger patient, it carries a greater risk of scarring and potential complications without guaranteed benefit.

   * **C) Loop Electrosurgical Excision Procedure (LEEP):** LEEP is a more aggressive procedure used for moderate to severe dysplasia and early invasive cancers. It involves removing a larger area of tissue. It’s typically not indicated for simple CIN I unless there are concerns about persistence or progression.

   * **D) Hysterectomy:** Removing the uterus is an extreme measure and completely inappropriate for a condition like CIN I. It’s only considered after other options have failed or in very specific circumstances related to reproductive health goals.


4. **Considering Clinical Guidelines:** Current guidelines from organizations such as the American Society for Colposcopy and Cervical Pathology strongly support watchful waiting with regular surveillance for CIN I in eligible patients (typically those under 50 with a high likelihood of regression).

Therefore, based on the patient's age, the severity of the finding (CIN I), and current best practices, close observation with scheduled screenings is the optimal initial management plan.

Answer: A
```
